Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

144 trials

NCT04975178
Recruiting
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Phase 3 · South Africa · 1 site
Registry update: 10 Feb 2025
NCT05824871
Recruiting
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · China · 2 sites
Registry update: 29 Jun 2025
NCT07811518
Recruiting
Latent Infection Freshmen Tracking for Tuberculosis
Phase 4 · China · 2 sites
Registry update: 10 Sept 2026
NCT06706596
Recruiting
A Systemic Screening for TB Disease in High-risk Groups in Barcelona
Not applicable · Spain · 1 site
Registry update: 29 Nov 2024
NCT05081401
Recruiting
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
Phase 3 · China · 5 sites
Registry update: 6 Apr 2025
NCT05317247
Recruiting
Cough Audio Classification as a TB Triage Test
Not applicable · Uganda, South Africa · 2 sites
Registry update: 6 May 2026
NCT05022862
Recruiting
Economic Incentives and vDOT for Latent Tuberculosis Infection
Not applicable · United States · 1 site
Registry update: 4 May 2026
NCT05588492
Recruiting
The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study
Phase 4 · Taiwan · 1 site
Registry update: 20 Oct 2022
NCT05426720
Recruiting
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
Not applicable · China · 2 sites
Registry update: 22 Jun 2022
NCT06764576
Recruiting
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
Not applicable · Italy · 1 site
Registry update: 8 Jan 2025
NCT05756582
Recruiting
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
Not applicable · Italy · 1 site
Registry update: 13 Feb 2024
NCT04923958
Recruiting
Rapid Research in Diagnostics Development for TB Network
Not applicable · Georgia, India, Nigeria, Philippines, Uganda, Vietnam, South Africa, Zambia · 16 sites
Registry update: 6 May 2026
NCT04700579
Recruiting
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
Not applicable · South Africa · 3 sites
Registry update: 6 May 2026
NCT04260477
Recruiting
Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · Niger · 1 site
Registry update: 13 Apr 2025
NCT04145258
Recruiting
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
Phase 3 · Côte d’Ivoire, Madagascar, Uganda, South Africa · 13 sites
Registry update: 24 Jun 2026
NCT04147286
Recruiting
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Phase 2/3 · South Africa · 1 site
Registry update: 23 Aug 2024
NCT04052022
Recruiting
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Not applicable · Mexico, United States · 3 sites
Registry update: 2 Nov 2026
NCT03474029
Recruiting
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Phase 2/3 · Australia, Benin, Canada, Haiti, Uganda, United States, Vietnam, South Africa · 21 sites
Registry update: 6 May 2026
NCT03625739
Recruiting
Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
Not applicable · China · 1 site
Registry update: 15 Aug 2018
NCT03691883
Recruiting
Design of an Integrative Algorithm for Staging Tuberculosis
Not applicable · Spain · 5 sites
Registry update: 27 Dec 2024

Ordered by registry start date. Freshness and sponsorship never change the order.